title: Vemurafenib for leptomeningeal melanomatosis.
authors: Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Centre, Bonn, Germany.
authors: Niklas
authors: N
authors: Schäfer
authors: Björn
authors: B
authors: Scheffler
authors: Moritz
authors: M
authors: Stuplich
authors: Christina
authors: C
authors: Schaub
authors: Sied
authors: S
authors: Kebir
authors: Claudia
authors: C
authors: Rehkämper
authors: Frederick
authors: F
authors: Mack
authors: Pitt
authors: P
authors: Niehusmann
authors: Matthias
authors: M
authors: Simon
authors: Susanne
authors: S
authors: Greschus
authors: Klaus
authors: K
authors: Kuchelmeister
authors: Ulrich
authors: U
authors: Herrlinger
authors: Martin
authors: M
authors: Glas
mesh_terms: D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy* / Q000235:genetics; D008577:Meningeal Neoplasms / Q000188:drug therapy* / Q000235:genetics; D008875:Middle Aged; D009154:Mutation; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors / Q000235:genetics; D013449:Sulfonamides / Q000627:therapeutic use*; D016896:Treatment Outcome; D000077484:Vemurafenib
chemical_list: D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; D048493:Proto-Oncogene Proteins B-raf